Option chain shows key data for Minera Alamos's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Minera Alamos.

Minera Alamos (OTC:MAIFF) Stock, Option Chain

Minera Alamos Inc is a junior mining and exploration company engaged directly and indirectly through its subsidiaries in the acquisition, exploration, and development of mineral properties located in Mexico. The Company operates in one business segment, mineral exploration, and two geographical segments, Canada and Mexico.

News

Small Cap

Markets

General

AMXEF

ANACONDA MINING INC by Anaconda Mining Inc.

ANXGF

ASCOT RESOURCES LTD by Ascot Resources Ltd.

AOTVF

LLKKF

SKREF

PAFRY

BNAUF

TSX:BNAU

GLVMF

TSXV:GZZ

NCAUF

TSXV:NCAU

FVANF

TSXV:FVAN

AGAUF

TSX:AZG

YGTFF

TSXV:YGT

TSX:SKE

CGLCF

TSXV:GLDC

JOSMF

TSX:JOSE

TSXV:AMX

OIIIF

TSXV:OIII

ORZCF

TSXV:ORE

MAIFF

TSXV:MAI

TSX:ANX

TSXV:RSLV

SHVLF

TSX:SAM

AAGFF

TSXV:AAG

MRDD

TSXV:OCG

FBSGF

TSXV:FCO

SLVRF

TSXV:SVE

SSVFF

TSXV:SSV

APGOF

TSXV:APGO

TSX:AOT

MMNGF

TSXV:MMG

BKRRF

TSXV:BRC

AVGDF

TSXV:AVG

CRCUF

TSX:CCM

BLTMF

TSXV:BLUE

PENMF

CNIKF

TSXV:CNC

AZMCF

TSXV:AMC

VMRSF

IONGF

TSXV:ION

AUIAF

TSXV:ARU

UEXCF

TSX:UEX

CYLYF

TSXV:CYL

STSBF

TSXV:STS

LITOF

TSXV:FL

MLLOF

TSXV:MDL

BLSTF

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

Metals &amp; Mining Companies Are Looking For Ways To Be More ESG-Friendly

Intraday Update

Movers

Trading Ideas

AAPL

ACGL

ACLS

ACRE

ADBE

ADSK

AGRO

AIQUY

AJMPF

ALGT

APAM

APTO

APTV

ARDX

ASMIY

ATVI

AWWI

AXAHF

AXAHY

AZNCF

BABA

BANF

BHLB

BMTC

BNDSY

BRBR

BXMT

CACI

CBRE

CBSH

CDAY

CHGS

CHRYY

CIVB

CMRE

COHU

CROX

CRTX

DIOD

EFSC

ELTZ

ENLAY

ENTG

EPAY

ESKYF

ESSYY

Eaton Vance Tax-Managed Diversified Equity

Eaton Vance Tax-Managed Global Diversified Equit

Stocks That Hit 52-Week Highs On Friday

AACAY

AAVVF

ADYEY

AFGC

AGPPF

AINV

ALLVF

ALPMF

AMGN

ANDA

ANGPY

ARGX

ASGLY

ASML

ASTE

ATLCY

AUPH

BBSEY

BFGIF

BKOR

BNPQF

BRK-A

BRK-B

BRKL

BROG

CBFV

CFST

CHGCY

CNNB

CNND

CREIY

CRUS

CSWI

CTYX

DCPH

DEER

DENR

DGDM

DSCSY

DSDVY

DSITF

EBSB

EFRTF

EGIF

ENIA

EPOKY

Eaton Vance Tax-Advantaged Global Dividend

FBMS

FCNCB

FERGY

FLEX

FNLC

FRME

FTAI

Stocks That Hit 52-Week Highs On Tuesday

Minera Alamos Inc

The global plant-based Active Pharmaceutical Ingredient (API) market is projected to grow at a steady pace, reaching a valuation of $52.1 billion by 2034, according to a <a href="https://www.futuremarketinsights.com/reports/plant-based-api-market">new report</a> by Future Market Insights. The industry is expected to expand at a Compound Annual Growth Rate (CAGR) of 5.6%, fueled by rising demand for natural and sustainable pharmaceutical solutions, including <a href="https://www.benzinga.com/markets/psychedelics">psychedelics</a> and <a href="https://www.benzinga.com/topic/cannabis-products">cannabis-derived</a> compounds.
<h3 class="wp-block-heading">Rising Demand For Psychedelic And Cannabis-Based Ingredients</h3>
A significant driver of market growth is the increasing use of psychoactive and plant-derived substances in modern pharmacology. Psychedelics like <a href="https://www.benzinga.com/topic/psilocybin">psilocybin</a> and cannabinoids such as <a href="https://www.benzinga.com/topic/cbd">CBD</a> and <a href="http://v">THC</a> are gaining attention for their <a href="http://v">therapeutic potential</a> in mental health and oncology. The U.S., a key player in the market, is leveraging biotechnological advances like <a href="https://www.genome.gov/genetics-glossary/CRISPR#:~:text=CRISPR%20(short%20for%20%E2%80%9Cclustered%20regularly,editing%20systems%20found%20in%20bacteria.">CRISPR</a> and synthetic biology to scale production of these high-demand APIs, contributing to a 4.2% CAGR.
"The global shift toward sustainable, plant-based solutions reflects both consumer interest in natural medicine and the pharmaceutical industry's focus on alternative therapies," said Sabyasachi Ghosh, associate VP at Future Market Insights. The market&#8217;s rapid expansion underscores the increasing acceptance of psychedelics and cannabis as mainstream pharmaceutical ingredients.
<h3 class="wp-block-heading">Therapeutic Applications And Key Botanical Sources</h3>
Plant-based APIs are harnessed from well-documented medicinal plants such as cannabis, ginseng, turmeric and cinchona. These natural sources contain bioactive compounds like flavonoids, terpenes and alkaloids, offering various therapeutic benefits. Major applications of plant-based APIs include pain management, anti-inflammatory treatments and oncology therapies.
The incorporation of cannabinoids, particularly CBD and THC, into pharmaceutical formulations is reshaping the landscape of pain and anxiety treatments. Similarly, psychoactive compounds from plants like Syrian rue and Psilocybe mushrooms are being explored for treating mental health disorders like depression and PTSD.
<h3 class="wp-block-heading">Regional Growth And Market Segmentation</h3>
The report highlights robust growth in Asian markets, with India leading at an 8.8% CAGR, followed closely by China (8.7%) and South Korea (8.6%). These regions are investing heavily in agricultural biotechnologies and expanding their capabilities in plant-based pharmaceutical production.
The market segments by product type, covering alkaloids, cannabinoids, <a href="https://www.benzinga.com/markets/cannabis/24/05/39064102/cannabis-terpenes-alleviate-chemo-induced-neuropathic-pain-study-shows-added-benefits-with-morph">terpenes</a>, flavonoids and polyphenols. It also includes API forms like extracts, powders and resins from botanicals such as opium poppy, turmeric, ginseng and cannabis.
<h3 class="wp-block-heading">Competitive Landscape: Psychedelics And Cannabis Companies Lead the Charge</h3>
The plant-based API sector is experiencing intense competition, particularly in the cannabis and psychedelics segments. Companies are rapidly scaling production and forming key partnerships to meet the rising demand for plant-based, pharmaceutical-grade ingredients.
Recent developments include Bright Green Corporation's agreement to supply <a href="https://www.benzinga.com/24/02/37292778/dea-clears-this-nasdaq-traded-plant-touching-firm-to-research-and-produce-schedule-i-and-ii-plant-ba">DEA-approved marijuana</a> extracts and psychedelic compounds to Benuvia Operations. Indena's authorization from Italian regulators to produce pharmaceutical-grade CBD further illustrates the expanding global footprint of cannabis-derived APIs.
Key players in the industry include the Illinois-based Abbott (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), New Mexico&#8217;s Bright Green Corporation, Indena S.p.A., headquartered in Milan, Italy, Alchem International Pvt. Ltd., based in India, Israeli Teva Pharmaceutical Industries Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>); Roquette Frères, based in Lestrem, France; and Sami-Sabinsa Group, based in New Jersey.
<h3 class="wp-block-heading">The Future Of Plant-Based APIs: Sustainable And Psychedelic Solutions</h3>
The growing demand for sustainable, natural treatments will likely position the plant-based API market at the forefront of global healthcare. As pharmaceutical companies continue to explore the therapeutic potential of bioactive compounds from plants, the integration of psychedelics and cannabis-derived APIs is likely to play a pivotal role in shaping the next decade of medicine.
Cover image made with AI

Cannabis

Market Summary

Psychedelics

Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids

Comments

Minera Alamos

Minera Alamos (MAIFF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga